8-K 1 form8k.htm DELCATH SYSTEMS, INC. FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 18, 2011 (November 15, 2011)
DELCATH SYSTEMS, INC.
(Exact name of registrant as specified in its charter)

Delaware | 001-16133 | 06-1245881
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification Number)

810 Seventh Avenue, 35th Floor, New York, New York, 10019
(Address of principal executive offices, including zip code)
(212) 489-2100
(Registrant’s telephone number, including area code)
NONE
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01. Regulation FD Disclosure.
A copy of Delcath Systems, Inc.’s updated investor presentation slides that the Company presented at the Lazard Capital Markets’ Eighth Annual Healthcare Conference on Tuesday, November 15, 2011 and intends to use effective immediately is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference.
The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

Item 9.01. Financial Statements and Exhibits.
The following exhibit is filed herewith:
(d) Exhibits.

Exhibit No. |  | Description
99.1 |  | Delcath Systems, Inc. Investor Presentation Slides

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|  | DELCATH SYSTEMS, INC. |
Dated: November 18, 2011 |  | By: | /s/ Peter J. Graham |
|  | Name: | Peter J. Graham |
|  | Title: | Executive Vice President, General Counsel |

EXHIBIT INDEX

Exhibit No. |  | Description
99.1 |  | Delcath Systems, Inc. Investor Presentation Slides